Please assess the completion status of the following clinical trial:

Trial Title: DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18 years.~* CKD stage 3 or 4 (MDRD-GFR 15-60 ml/min)~* Use of any anti-hypertensive drugs~* No anti-hypertensive drugs but an average office systolic blood pressure \> 140 mmHg (as measured by datascope)~Exclusion Criteria:~* Salt-wasting CKD~* Nephrotic syndrome~* Pregnant or breastfeeding women~* Life expectancy \< 6 months~* Severe heart failure (NYHA III or IV) or liver cirrhosis with ascites and the inability to withdraw diuretics~* Rapidly declining kidney function with high likelihood of dialysis or kidney transplantation in the coming 4 months~* Kidney transplant recipients~* Use of immunosuppressive drugs~* Use of non-steroidal anti-inflammatory drugs~* Previous intolerance or allergy to hydrochlorothiazide or amiloride~* Serum sodium \< 135 mmol/l~* Serum potassium \< 3.5 mmol/l or \> 5.0 mmol/l~* Inability to adhere to the study protocol (due to language, incapacitated subjects, subjects with intellectual disability)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- Diuretic treatment (Type: ACTIVE_COMPARATOR): Patients receive amiloride and hydrochlorothiazide
- Low-sodium diet (Type: ACTIVE_COMPARATOR): Patients are put on a low-sodium diet (60 mmol/day)

Based on this trial design, predict the completion outcome and termination type (if applicable).